INGN logo

Inogen Inc (INGN)

$5.69

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on INGN

Market cap

$147821836

EPS

-1.31

P/E ratio

--

Price to sales

0.46

Dividend yield

--

Beta

1.516051

Price on INGN

Previous close

$5.63

Today's open

$5.58

Day's range

$5.52 - $5.73

52 week range

$5.05 - $7.67

Profile about INGN

CEO

Kevin R.M. Smith

Employees

753

Headquarters

Beverly, MA

Exchange

Nasdaq Global Select

Shares outstanding

26002082

Issue type

Common Stock

INGN industries and sectors

Healthcare

Medical Equipment & Supplies

News on INGN

Inogen, Inc. (INGN) Q3 2026 Earnings Call Transcript

Inogen, Inc. ( INGN ) Q3 2026 Earnings Call November 5, 2026 5:00 PM EST Company Participants Lorna Williams - Senior Vice President of Investor Relations Andrew Reding - President, CEO & Director Jason Richardson - CFO, Executive VP & Treasurer Presentation Operator Welcome to Inogen's Third Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, November -- as a reminder, this conference is being recorded today, November 5, 2026.

news source

Seeking Alpha • Nov 6, 2026

news preview

What Inogen (INGN) Said on Its Q3 Earnings Call

Inogen NASDAQ: INGN reported lower third-quarter revenue as weaker spending by large European customers offset a return to growth in U.S. sales. The respiratory care company also outlined a $20 million annualized cost-reduction program following the sale of its U.S. oxygen rental business.

news source

MarketBeat • Nov 6, 2026

news preview

Inogen Announces Third Quarter 2026 Financial Results

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Appoints Andy Reding as President and Chief Executive Officer; Company initiates a $20 million cost reduction program to accelerate profitability.

news source

Business Wire • Nov 5, 2026

news preview

Inogen Announces Leadership Transition

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Leadership Transition; Chief Operating Officer Andy Reding Appointed President and Chief Executive Officer.

news source

Business Wire • Nov 5, 2026

news preview

Inogen: Cheap Enough To Take A Chance On

Inogen, Inc. (INGN) is upgraded to Buy, driven by operational improvement with support from a robust balance sheet. INGN's $45m share buyback, debt-free status, and cash/investments covering ~61% of market cap provide downside protection and acquisition appeal. Management turnover and anemic 2026 revenue growth guidance (3% at midpoint) remain risks, but operational improvements are emerging.

news source

Seeking Alpha • Oct 20, 2026

news preview

Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report Third Quarter 2026 Financial Results on November 5, 2026.

news source

Business Wire • Oct 15, 2026

news preview

Inogen Announces Divestiture of Its U.S. Oxygen Rental Business to Rotech

BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--INOGEN ANNOUNCES DIVESTITURE OF ITS U.S. OXYGEN RENTAL BUSINESS TO ROTECH.

news source

Business Wire • Sep 30, 2026

news preview

Here's Why You Should Retain Inogen Stock in Your Portfolio for Now

INGN's POC demand, new products and international growth support its outlook, while U.S. channel shifts and distributor timing pose risks.

news source

Zacks Investment Research • Aug 21, 2026

news preview

Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists

INGN cuts its 2026 revenue outlook as U.S. channel pressure weighs, while international growth, new products and cost control offer support.

news source

Zacks Investment Research • Aug 11, 2026

news preview

Should Investors Buy Inogen as Low Valuation Meets Execution Risk?

Inogen's steep sales-multiple discount, improving margins and firm international demand clash with U.S. sales and rental weakness.

news source

Zacks Investment Research • Aug 11, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Inogen Inc

Open an M1 investment account to buy and sell Inogen Inc commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in INGN on M1